BCC Research
Market Research Reports and Technical PublicationsArchive for July 24, 2008
$300m shot in the arm for Merck’s vaccines plant
US drug giant Merck & Co hopes that an additional $300m investment in its vaccine manufacturing plant in Durham, North Carolina will cement its position at the forefront of the global vaccines market.¹
¹Gareth McDonald; In-PharmaTechnologist.com
